KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2016 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Asset Utilization Ratio for 16 consecutive years, with 0.42 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Asset Utilization Ratio rose 12.98% year-over-year to 0.42, compared with a TTM value of 0.42 through Jun 2025, up 12.98%, and an annual FY2025 reading of 0.44, up 7.05% over the prior year.
  • Asset Utilization Ratio was 0.42 for Q2 2025 at Biomarin Pharmaceutical, up from 0.42 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.42 in Q2 2025 and bottomed at 0.31 in Q4 2021.
  • Average Asset Utilization Ratio over 5 years is 0.36, with a median of 0.34 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio decreased 4.24% in 2021, then increased 15.8% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.31 in 2021, then increased by 7.63% to 0.33 in 2022, then rose by 2.3% to 0.34 in 2023, then rose by 21.54% to 0.41 in 2024, then rose by 1.74% to 0.42 in 2025.
  • Business Quant data shows Asset Utilization Ratio for BMRN at 0.42 in Q2 2025, 0.42 in Q1 2025, and 0.41 in Q4 2024.